Hot Pursuit     05-Apr-22
Alembic Pharmaceuticals Ltd soars 1.11%
Alembic Pharmaceuticals Ltd is quoting at Rs 764.2, up 1.11% on the day as on 12:54 IST on the NSE. The stock is down 21.44% in last one year as compared to a 22.63% gain in NIFTY and a 10.4% gain in the Nifty Pharma index.

Alembic Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 764.2, up 1.11% on the day as on 12:54 IST on the NSE. The benchmark NIFTY is down around 0.26% on the day, quoting at 18006.7. The Sensex is at 60373.63, down 0.39%. Alembic Pharmaceuticals Ltd has added around 7.69% in last one month.

Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has added around 10.41% in last one month and is currently quoting at 13789.25, up 0.47% on the day. The volume in the stock stood at 1.09 lakh shares today, compared to the daily average of 2.65 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 768.3, up 1.23% on the day. Alembic Pharmaceuticals Ltd is down 21.44% in last one year as compared to a 22.63% gain in NIFTY and a 10.4% gain in the Nifty Pharma index.

The PE of the stock is 19.21 based on TTM earnings ending December 21.

Previous News
  Alembic Pharma gets US FDA nod for heart failure-treatment drug
 ( Hot Pursuit - 30-May-24   14:05 )
  Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
 ( Hot Pursuit - 24-Aug-24   16:59 )
  Alembic Pharma hits record high on USFDA nod for anti psychotic drug
 ( Hot Pursuit - 24-Jul-24   14:43 )
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Alembic Pharmaceuticals consolidated net profit declines 18.68% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   14:55 )
  Alembic Pharmaceuticals EGM scheduled
 ( Corporate News - 12-May-22   11:15 )
  Alembic Pharmaceuticals AGM scheduled
 ( Corporate News - 06-Jun-23   18:21 )
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
  Alembic Pharma gets PAS nod from USFDA for pregabalin capsules
 ( Hot Pursuit - 22-Dec-22   14:57 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Intellect Design Arena Ltd leads losers in 'A' group
 ( Hot Pursuit - 10-May-24   15:00 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top